Endometrial carcinoma: molecular alterations involved in tumor development and progression
出版年份 2012 全文链接
标题
Endometrial carcinoma: molecular alterations involved in tumor development and progression
作者
关键词
-
出版物
ONCOGENE
Volume 32, Issue 4, Pages 403-413
出版商
Springer Nature
发表日期
2012-03-19
DOI
10.1038/onc.2012.76
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia
- (2012) Maria Santacana et al. HISTOPATHOLOGY
- KSR1 Is Overexpressed in Endometrial Carcinoma and Regulates Proliferation and TRAIL-Induced Apoptosis by Modulating FLIP Levels
- (2011) David Llobet et al. AMERICAN JOURNAL OF PATHOLOGY
- Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma
- (2011) Bin Guan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- PIK3R1 (p85 ) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
- (2011) M. E. Urick et al. CANCER RESEARCH
- A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas
- (2011) Meghan L. Rudd et al. CLINICAL CANCER RESEARCH
- cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer
- (2011) Yonghua Chen et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma
- (2011) Nuria Montserrat et al. HUMAN PATHOLOGY
- ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells
- (2011) Marta Llauradó et al. INTERNATIONAL JOURNAL OF CANCER
- Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
- (2011) Kimberly C Wiegand et al. JOURNAL OF PATHOLOGY
- Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner
- (2011) Andree Yeramian et al. LABORATORY INVESTIGATION
- FGFR2 alterations in endometrial carcinoma
- (2011) Sonia Gatius et al. MODERN PATHOLOGY
- The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms
- (2010) D. Llobet et al. EUROPEAN JOURNAL OF CANCER
- Molecular alterations in uterine serous carcinoma
- (2010) Monica Prasad Hayes et al. GYNECOLOGIC ONCOLOGY
- Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma
- (2010) Ana Velasco et al. HUMAN PATHOLOGY
- Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma☆
- (2010) Jesús Planagumà et al. HUMAN PATHOLOGY
- Gene Expression Profiling of Endometrial Adenocarcinomas Reveals Increased Apolipoprotein E Expression in Poorly Differentiated Tumors
- (2010) Jutta Huvila et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Molecular classification of human endometrial cancer based on gene expression profiles from specialized microarrays
- (2010) YuanYang Yao et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma
- (2010) María Ángeles Castilla et al. JOURNAL OF PATHOLOGY
- Expression profiling of 22 genes involved in the PI3K–AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations
- (2010) Lluis Catasus et al. MODERN PATHOLOGY
- Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms
- (2010) Laura J Tafe et al. MODERN PATHOLOGY
- PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
- (2010) K. J. Dedes et al. Science Translational Medicine
- Introduction
- (2010) Xavier Matias-Guiu et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Pathologic and molecular features of uterine carcinosarcomas
- (2010) Maria-Angeles Lopez-Garcia et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Endometrial carcinomas with ambiguous features
- (2010) Robert A. Soslow SEMINARS IN DIAGNOSTIC PATHOLOGY
- Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma
- (2009) Monica Prasad Hayes et al. GYNECOLOGIC ONCOLOGY
- Subtractive Proteomic Approach to the Endometrial Carcinoma Invasion Front
- (2009) Marta Monge et al. JOURNAL OF PROTEOME RESEARCH
- Concomitant PI3K–AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis
- (2009) Lluis Catasus et al. MODERN PATHOLOGY
- CK2β Is Expressed in Endometrial Carcinoma and Has a Role in Apoptosis Resistance and Cell Proliferation
- (2008) Judit Pallares et al. AMERICAN JOURNAL OF PATHOLOGY
- Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas
- (2008) E Bignotti et al. BRITISH JOURNAL OF CANCER
- NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
- (2008) V. Serra et al. CANCER RESEARCH
- Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints
- (2008) D Llobet et al. JOURNAL OF CLINICAL PATHOLOGY
- Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma
- (2008) Judit Pallarés et al. MODERN PATHOLOGY
- Drug-sensitive FGFR2 mutations in endometrial carcinoma
- (2008) A. Dutt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search